Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
We recommend LINOFIT instead of Linowin. Exact salt composition from top brand
100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothLinezolid 600mg
Salt CompositionLinezolid 600mg (same for both)
Linowin 600mg Tablet 10s
You Searched
Linowin 600mg Tablet 10s
Hetero Healthcare Ltd.
Linowin 600mg Tablet 10s
Hetero Healthcare Ltd.
₹399
Our Recommendation
Linofit 600mg Tablet 4s
Dr. Morepen Ltd.
4,974+ Customers trust this
WHO GMP Certified
Assured by
Assured
Linofit 600mg Tablet 4s
Assured by
Assured
4,974+ trust this
WHO GMP Certified
Customers also bought
More About Linowin
Benefits
In Treatment of Severe bacterial infections Linowin 600mg Tablet works by killing bacteria which can cause serious infections. It is used to treat many different types of bacterial infections such as infections of lungs (pneumonia), skin, and soft tissues. This medicine usually makes you feel better very quickly but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Linowin 600mg Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time. Avoid Linowin 600mg Tablet with tyramine-rich food such as cheese, smoked fish, meats and some types of beer.
How it works
Linowin 600mg Tablet is an antibiotic. It stops bacterial growth by preventing synthesis of essential proteins required by bacteria to carry out vital functions.
Unsafe: Avoid consuming alcohol with Linowin 600mg Tablet as it is deemed unsafe.
Seek medical advice from your doctor: Linowin 600mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Linowin 600mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Not Safe: Linowin 600mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Safe when prescribed by an expert: Linowin 600mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Linowin 600mg Tablet is recommended. However, talk to your doctor if you have any underlying kidney disease.
Caution Advised: Linowin 600mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Linowin 600mg Tablet may be needed. Doctor consultation is advised. Limited information is available on the use of Linowin 600mg Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
What if I forget to take it?
If a dose of Linowin 600mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
7-2-A2, Hetero Corporate, Industrial Estates, Sanath Nagar, Hyderabad ‚ 500 018. Telangana, INDIA
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
